Results 31 to 40 of about 79,337 (314)

Novel therapeutic strategies for injured endometrium: intrauterine transplantation of menstrual blood‑derived cells from infertile patients

open access: yesStem Cell Research & Therapy, 2023
Background Menstrual blood-derived cells show regenerative potential as a mesenchymal stem cell and may therefore be a novel stem cell source of treatment for refractory infertility with injured endometrium.
Satoshi Hosoya   +10 more
doaj   +1 more source

Mesenchymal Stem Cells and Clinical Application in Chronic Lung Diseases

open access: yesJurnal Respirasi, 2021
Mesenchymal stem cells are a multipotent mature non hematopoietic stem cells, with characteristics such as ability to self-renew and differentiate in mesodermal, ectodermal, and endodermal pathway.
Isti Mardiana Soetartio, Triya Damayanti
doaj   +1 more source

The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation [PDF]

open access: yesExperimental & Molecular Medicine, 2013
In the last 10 years, mesenchymal stem cells (MSCs) have emerged as a therapeutic approach to regenerative medicine, cancer, autoimmune diseases, and many more due to their potential to differentiate into various tissues, to repair damaged tissues and organs, and also for their immunomodulatory properties.
Eun Jung Kim, Seok-Goo Cho, Nayoun Kim
openaire   +3 more sources

Encapsulation of Mesenchymal Stem Cells: Dissecting the Underlying Mechanism of Mesenchymal Stem Cell Transplantation Therapy [PDF]

open access: yesNeuroscience Insights, 2020
Mesenchymal stem cells (MSCs) are widely considered good candidates for cell transplantation therapy. Various central nervous system disorders have been suggested as suitable targets for MSC transplantation therapy. In this context, a great deal of basic and clinical research has been conducted to explore its clinical uses.
Kyohei Kin, Takao Yasuhara, Isao Date
openaire   +4 more sources

Mesenchymal stem cells for kidney transplantation

open access: yesWorld Journal of Clinical Urology, 2014
Published online: July 24, 2014 ; The long term consequence of immunosuppressive therapy in kidney transplantation has prompted investigation of alternative means to modify the immune response to the allograft. Cell based therapies are potentially attractive as they may provide a long lasting immunomodulatory effect, may repair tissues and reduce the ...
Lett, B., Sivanathan, K., Coates, P.
openaire   +3 more sources

ADMINISTRATION OF BONE MARROW DERIVED MESENCHYMAL STEM CELLS MODULATE TLR EXPRESSION DURING LIVER REGENERATION

open access: yesTrakya University Journal of Natural Sciences, 2019
Liver cell transplantation is a powerful alternative to orthotopic cell transplantation in the treatment of liver failures. Recently, considerable effort is being channeled to understand the nature and kinetics of directing stem cells to effectively ...
İhsan Gursel   +4 more
doaj   +1 more source

Melatonin, tunneling nanotubes, mesenchymal cells, and tissue regeneration

open access: yesNeural Regeneration Research, 2023
Mesenchymal stem cells are multipotent stem cells that reside in many human tissues and organs. Mesenchymal stem cells are widely used in experimental and clinical regenerative medicine due to their capability to transdifferentiate into various lineages.
Francesca Luchetti   +4 more
doaj   +1 more source

Safety in mesenchymal stem cell transplantation [PDF]

open access: yesBiomedical Research and Therapy, 2014
To date, adult stem cell therapy has some achievements in the treatment of chronic disease. However, some risks in stem cell transplantation still serve as high barriers obstructing the pulling of these therapies into clinical use. Tumorigenecity is of almost concern after it is injected into patients.
openaire   +1 more source

Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells [PDF]

open access: yesLeukemia, 2007
Seven patients underwent treatment with mesenchymal stem cells (MSCs), together with allogeneic hematopoietic stem cell transplantation (HSCT). MSCs were given to three patients for graft failure and four patients were included in a pilot study. HSCT donors were three human leukocyte antigen (HLA)-identical siblings, three unrelated donors and one cord
Johan Arvidson   +9 more
openaire   +3 more sources

Propofol combined with bone marrow mesenchymal stem cell transplantation improves electrophysiological function in the hindlimb of rats with spinal cord injury better than monotherapy

open access: yesNeural Regeneration Research, 2015
The repair effects of bone marrow mesenchymal stem cell transplantation on nervous system damage are not satisfactory. Propofol has been shown to protect against spinal cord injury. Therefore, this study sought to explore the therapeutic effects of their
Yue-xin Wang   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy